National Toxicology Program (NTP); Report on Carcinogens Review Process for the 12th Report on Carcinogens (RoC), 18999 [E7-7111]

Download as PDF Federal Register / Vol. 72, No. 72 / Monday, April 16, 2007 / Notices assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. Members of the public will have the opportunity to provide comments at the meeting. Individuals who wish to address the Committee during the public comment session must pre-register by May 11, 2007. Any individual who wishes to participate in the public comment session should call the telephone number listed in the contact information to register. Public comments will be limited to five minutes per speaker. Members of the public who wish to have printed material distributed to CFSAC members for discussion should submit, at a minimum, one copy of the material to the Executive Secretary, CFSAC, prior to close of business on May 11, 2007. Contact information for the Executive Secretary, CFSAC, is listed above. Dated: April 10, 2007. Anand K. Parekh, Executive Secretary, Chronic Fatigue Syndrome Advisory Committee. [FR Doc. E7–7130 Filed 4–13–07; 8:45 am] BILLING CODE 4150–42–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Toxicology Program (NTP); Report on Carcinogens Review Process for the 12th Report on Carcinogens (RoC) National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), Department of Health and Human Services. AGENCY: ACTION: Notice. SUMMARY: The NTP announces its scientific review process to review nominations for the 12th RoC. The process is available on the NTP Web site https://ntp.niehs.nih.gov (select ‘‘Report on Carcinogens’’) or by contacting Dr. C.W. Jameson at the address provided below. All correspondence should be directed to Dr. C.W. Jameson, National Toxicology Program, Report on Carcinogens, 79 Alexander Drive, Building 4401, Room 3118, P.O. Box 12233, Research Triangle Park, NC 27709; telephone: (919) 541–4096, fax: (919) 541–0144, e-mail: jameson@niehs.nih.gov. cprice-sewell on PROD1PC66 with NOTICES ADDRESSES: SUPPLEMENTARY INFORMATION: VerDate Aug<31>2005 15:24 Apr 13, 2007 Jkt 211001 Background On August 17, 2006, the NTP released its draft review process applicable for nominations to the 12th RoC (71 FR 47507) and invited public comment. The NTP considered all comments received and now announces the final RoC review process for the 12th RoC. Two important elements in the RoC review process are (1) the public peer review of draft background documents by ad hoc scientific expert panels and (2) the public peer review of draft substance profiles by the NTP Board of Scientific Counselors. In addition, the NTP will also, on a trial basis, prepare a response to public comments for the 12th RoC. The RoC review process is described in more detail on the NTP Web site (https://ntp.niehs.nih.gov/ select ‘‘Report on Carcinogens’’). Background Information on the Report on Carcinogens The RoC is a congressionally mandated document (Section 301(b)(4) of the Public Health Services Act, 42 U.S.C. 241(b)(4)), published by the Secretary of Health and Human Services (HHS), that identifies agents, substances, mixtures, or exposure circumstances (collectively referred to as ‘‘substances’’) that may pose a carcinogenic hazard to human health. The Secretary, HHS, has delegated responsibility for preparing the draft report to the NTP. Substances are listed in the RoC as either known to be a human carcinogen or reasonably anticipated to be a human carcinogen. Review of nominations involves a multistep scientific review process with opportunity for public comment. At the end of this process, NTP forwards a draft RoC to the Secretary for review, approval, and transmittal to Congress and the public. The NTP solicits and encourages the broadest participation from interested individuals or parties in nominating substances for review for future RoCs. Nominations should contain a rationale for review. Appropriate background information and relevant data [e.g., journal articles, NTP Technical Reports, International Agency for Research on Cancer (IARC) listings, exposure surveys, release inventories, etc.] that support the review of a nomination should be provided or referenced when possible. Contact information for the nominator should also be included [name, affiliation (if any), address, telephone, fax, and e-mail]. PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 18999 Dated: March 19, 2007. David A. Schwartz, Director, National Institute of Environmental Health Science and National Toxicology Program. [FR Doc. E7–7111 Filed 4–13–07; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Office for Civil Rights; Delegations of Authority Notice is hereby given that I have delegated to the Director of the Office for Civil Rights the following authority vested in the Secretary of Health and Human Services. A. Subpoenas for the Health Insurance Portability and Accountability Act of 1996: Authority under Section 205(d) of the Social Security Act (42 U.S.C. 405(d)), with authority to redelegate, to issue subpoenas requiring the attendance and testimony of witnesses and the production of any evidence that relates to any matter under investigation or compliance review for failure to comply with the Health Insurance Portability and Accountability Act of 1996 (HIPAA) standards and requirements related to the privacy of individually identifiable health information at 45 CFR parts 160 and 164. Section 1176(a)(2) of the Social Security Act, 42 U.S.C. 1320d–5(a)(2), which provides authority for the imposition of civil money penalties (CMPs) for violations, makes section 1128A of the Social Security Act, 42 U.S.C. 1320a–7a, applicable to the imposition of CMPs for violations of the HIPAA administrative simplification standards. Section 1128A(j)(1), 42 U.S.C. 1320a–7a(j)(1), makes section 205(d) and (e) of the Social Security Act, 42 U.S.C. 405(d) and (e), applicable to section 1128A as the subsections are with respect to Title II of the Social Security Act. Section 205(d) and (e) authorizes the issuance of subpoenas requiring the attendance and testimony of witnesses and the production of any evidence that relates to any matter under investigation by the Secretary and the enforcement of such a subpoena in court in event of refusal to comply. B. Subpoenas for the Patient Safety and Quality Improvement Act of 2005: Authority under Section 205(d) of the Social Security Act (42 U.S.C. 405(d)), with authority to redelegate, to issue subpoenas requiring the attendance and testimony of witnesses and the production of any evidence that relates E:\FR\FM\16APN1.SGM 16APN1

Agencies

[Federal Register Volume 72, Number 72 (Monday, April 16, 2007)]
[Notices]
[Page 18999]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-7111]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Toxicology Program (NTP); Report on Carcinogens Review 
Process for the 12th Report on Carcinogens (RoC)

AGENCY: National Institute of Environmental Health Sciences (NIEHS), 
National Institutes of Health (NIH), Department of Health and Human 
Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The NTP announces its scientific review process to review 
nominations for the 12th RoC. The process is available on the NTP Web 
site https://ntp.niehs.nih.gov (select ``Report on Carcinogens'') or by 
contacting Dr. C.W. Jameson at the address provided below.

ADDRESSES: All correspondence should be directed to Dr. C.W. Jameson, 
National Toxicology Program, Report on Carcinogens, 79 Alexander Drive, 
Building 4401, Room 3118, P.O. Box 12233, Research Triangle Park, NC 
27709; telephone: (919) 541-4096, fax: (919) 541-0144, e-mail: 
jameson@niehs.nih.gov.

SUPPLEMENTARY INFORMATION: 

Background

    On August 17, 2006, the NTP released its draft review process 
applicable for nominations to the 12th RoC (71 FR 47507) and invited 
public comment. The NTP considered all comments received and now 
announces the final RoC review process for the 12th RoC. Two important 
elements in the RoC review process are (1) the public peer review of 
draft background documents by ad hoc scientific expert panels and (2) 
the public peer review of draft substance profiles by the NTP Board of 
Scientific Counselors. In addition, the NTP will also, on a trial 
basis, prepare a response to public comments for the 12th RoC. The RoC 
review process is described in more detail on the NTP Web site (https://
ntp.niehs.nih.gov/ select ``Report on Carcinogens'').

Background Information on the Report on Carcinogens

    The RoC is a congressionally mandated document (Section 301(b)(4) 
of the Public Health Services Act, 42 U.S.C. 241(b)(4)), published by 
the Secretary of Health and Human Services (HHS), that identifies 
agents, substances, mixtures, or exposure circumstances (collectively 
referred to as ``substances'') that may pose a carcinogenic hazard to 
human health. The Secretary, HHS, has delegated responsibility for 
preparing the draft report to the NTP. Substances are listed in the RoC 
as either known to be a human carcinogen or reasonably anticipated to 
be a human carcinogen. Review of nominations involves a multi-step 
scientific review process with opportunity for public comment. At the 
end of this process, NTP forwards a draft RoC to the Secretary for 
review, approval, and transmittal to Congress and the public.
    The NTP solicits and encourages the broadest participation from 
interested individuals or parties in nominating substances for review 
for future RoCs. Nominations should contain a rationale for review. 
Appropriate background information and relevant data [e.g., journal 
articles, NTP Technical Reports, International Agency for Research on 
Cancer (IARC) listings, exposure surveys, release inventories, etc.] 
that support the review of a nomination should be provided or 
referenced when possible. Contact information for the nominator should 
also be included [name, affiliation (if any), address, telephone, fax, 
and e-mail].

    Dated: March 19, 2007.
David A. Schwartz,
Director, National Institute of Environmental Health Science and 
National Toxicology Program.
[FR Doc. E7-7111 Filed 4-13-07; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.